BECTON DICKINSON & CO
8-K, 1996-10-15
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: BARRINGER TECHNOLOGIES INC, 8-K, 1996-10-15
Next: BINKS MANUFACTURING CO, 10-Q, 1996-10-15



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549


                                   FORM 8-K

                                CURRENT REPORT


                    Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)  October 8, 1996
                                                  ---------------


                         BECTON, DICKINSON AND COMPANY
- --------------------------------------------------------------------------------
            (Exact name of registrant as specified in its charter)

           New Jersey                  1-4802                   22-0760120
- --------------------------------------------------------------------------------
    (State or other juris-         (Commission             (IRS Employer Iden-
   diction of incorporation)       File Number)            tification Number)


   1 Becton Drive, Franklin Lakes, New Jersey                   07417-1880
- --------------------------------------------------------------------------------
    (Address of principal executive offices)                    (Zip Code)


Registrant's telephone number, including area code          (201) 847-6800
                                                            --------------

                                      N/A
- --------------------------------------------------------------------------------
        (Former name or former addresses if changed since last report.)
<PAGE>
 
Item 7.  Financial Statements and Exhibits
         ---------------------------------

         The Registrant is filing herewith the exhibits referenced in the Index 
         of Exhibits annexed hereto and made a part hereof.


                                     - 2 -
<PAGE>
 
                                  SIGNATURES


        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the 
undersigned hereunto duly authorized.

                                           BECTON, DICKINSON AND COMPANY
                                                  (Registrant)
                                    
                                    
                                    
                                           By: /s/ Raymond P. Ohlmuller
                                               ----------------------------
                                                   Raymond P. Ohlmuller
                                               Vice President and Secretary


Date: October 15, 1996

                                     - 3 -
<PAGE>
 
                               INDEX TO EXHIBITS
                               -----------------

Exhibit 
Number             Description of Exhibits
- -------            -----------------------

1                  Pricing Agreement dated October 8, 1996 between
                   the Registrant and Goldman, Sachs & Co.

4(d)               Form of Definitive Global 6.9% Note Due
                   October 1, 2006

                                     - 4 -

<PAGE>
 
                                                                       EXHIBIT 1



                               Pricing Agreement
                               -----------------



Goldman, Sachs & Co.,
85 Broad Street,
New York, New York 10004


                                                                 October 8, 1996


Dear Sirs:

        Becton, Dickinson and Company, a New Jersey corporation (the "Company"),
proposes, subject to the terms and conditions stated herein and in the 
Underwriting Agreement, dated January 10, 1995 (the "Underwriting Agreement"), 
to issue and sell to the Underwriters named in Schedule 1 hereto (the 
"Underwriters") the Securities specified in Schedule II hereto (the "Designated 
Securities").  Each of the provisions of the Underwriting Agreement is 
incorporated herein by reference in its entirety, and shall be deemed to be a 
part of this Agreement to the same extent as if such provisions had been set 
forth in full herein; and each of the representations and warranties set forth 
therein shall be deemed to have been made at and as of the date of this Pricing 
Agreement, except that each representation and warranty which refers to the 
Prospectus in Section 2 of the Underwriting Agreement shall be deemed to be a 
representation or warranty as of the date of the Underwriting Agreement in 
relation to the Prospectus (as therein defined), and also a representation and 
warranty as of the date of this Pricing Agreement in relation to the Prospectus 
as amended or supplemented relating to the Designated Securities which are the 
subject of this Pricing Agreement.  Each reference to the Representatives herein
and in the provisions of the Underwriting Agreement so incorporated by reference
shall be deemed to refer to you.  Unless otherwise defined herein, terms defined
in the Underwriting Agreement are used herein as therein defined.  The 
Representatives designated to act on behalf of the Representatives and on behalf
of each of the Underwriters of the Designated Securities pursuant to Section 12 
of the Underwriting Agreement and the address of the Representatives referred to
in such Section 12 are set forth at the end of Schedule II hereto.

        An amendment to the Registration Statement, or an amendment and 
supplement to the Prospectus, as the case may be, relating to the Designated 
Securities, in the form heretofore delivered to you is now proposed to be filed 
with the Commission.

        Subject to the terms and conditions set forth herein and in the 
Underwriting Agreement incorporated herein by reference, the Company agrees to 
issue and sell to the Underwriters, and the Underwriters agree to purchase from 
the Company, at the time and place and at the purchase price to the Underwriters
set forth in Schedule II hereto, the principal amount of Designated Securities 
set forth opposite the name of such Underwriter in Schedule I hereto.


        If the foregoing is in accordance with your understanding, please sign 
and return to us seven counterparts hereof, and upon acceptance hereof by you 
this letter and such
<PAGE>
 
acceptance hereof, including the provisions of the Underwriting Agreement 
incorporated herein by reference, shall constitute a binding agreement between 
you and the Company.

                                        Very truly yours,

                                        Becton, Dickinson and Company

                                        /s/ Geoffrey D. Cheatham
                                        By: ___________________________
                                            Name:  Geoffrey D. Cheatham
                                            Title:  Vice President and Treasurer


Accepted as of the date herof:


/s/ Goldman, Sachs & Co.
______________________________
   (Goldman, Sachs & Co.)


<PAGE>
 


                                  SCHEDULE I


                                                                 Principal
                                                                Amount of
                                                                Designated
                                                                Securities
                                                                   to be
Underwriter                                                      Purchased
- -----------                                                      ---------
                                                              
                                                              
                                                              
Goldman, Sachs & Co. ..............................           $100,000,000
                                                              
                                                              ------------
                 Total ............................           $100,000,000
                                                              ============


<PAGE>
 

                                  SCHEDULE II




Title of Designated Securities:

      6.90% Notes Due October 1, 2006
Aggregate principal amount:

      $100,000,000

Price to Public:

      99.861% of the principal amount of the Designated Securities

Purchase Price by Underwriters:

      99.211% of the principal amount of the Designated Securities

Form of Designated Securities

      Book-entry only form represented by one or more global securities
      deposited with The Depository Trust Company ("DTC") or its designated
      custodian.

Specified funds for payment of purchase price:

      Federal (same day) funds

Indenture:

      Indenture dated as of December 1, 1982, as supplemented as of May 15, 1986
      and January 10, 1995 (collectively, the "Indenture"), between the Company
      and The Chase Manhattan Bank (fomerly known as Chemical Bank), as 
      successor to Manufacturers Hanover Trust Company, as Trustee.

Maturity:

      October 1, 2006

Interest Rate:

      6.90%

Interest Payment Dates:

      April 1 and October 1, commencing April 1, 1997

Record Dates:

      March 15 and September 15

Redemption Provisions:

      No redemption provisions.

Sinking Fund Provisions:

      No sinking fund provisions.

Defeasance provisions:

      The defeasance provisions of the Indenture are applicable to the 
      Designated Securities.

Time of Delivery:

      10:00 a.m. (New York City time), October 11, 1996.

<PAGE>
 


Closing Location:

      Sullivan & Cromwell
      125 Broad Street
      New York, New York 10004

Names and addresses of Representatives:

      Goldman, Sachs & Co.

      85 Broad Street
      New York, New York 10004


<PAGE>
 
                                                                    EXHIBIT 4(d)


NOTE NO. G-1


                                                           CUSIP No. 075887 AM 1

        THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE
HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITORY OR A
NOMINEE THEREOF. THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A
SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART MAY BE
REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITORY OR A NOMINEE
THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE.

        UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE
DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION ("DTC") TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY SECURITY
ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND PAYMENT IS MADE TO CEDE &
CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO
ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS
AN INTEREST HEREIN.


                         BECTON, DICKINSON AND COMPANY

                        6.90% Notes Due October 1, 2006


        BECTON, DICKINSON AND COMPANY, a corporation organized and existing 
under the laws of the State of New Jersey (hereinafter called the "Company", 
which term includes any successor corporation under the Indenture hereinafter 
referred to), for value received, hereby promises to pay to Cede & Co. or 
registered assigns, the principal sum of 100,000,000 Dollars on October 1, 2006,
and to pay interest thereon from October 11, 1996 or from the most recent 
Interest Payment Date to which interest has been paid or duly provided for, 
semi-annually on April 1 and October 1 in each year, commencing April 1, 1997 at
the rate of 6.90% per annum, until the principal hereof is paid or made 
available for payment.  The interest so payable, and punctually paid or duly 
provided for, on any Interest Payment Date will, as provided in such Indenture, 
be paid to the Person in whose name this Security (or one or more Predecessor 
Securities) is registered at the close of business on the Regular Record Date 
for such interest, which shall be the March 15 or September 15 (whether or not a
Business Day), as the case may be, next preceding such 
<PAGE>
 
Interest Payment Date. Any such interest not so punctually paid or duly provided
for will forthwith cease to be payable to the Holder on such Regular Record Date
and may either be paid to the Person in whose name this Security (or one or more
Predecessor Securities) is registered at the close of business on a Special 
Record Date for the payment of such Defaulted Interest to be fixed by the 
Trustee, notice whereof shall be given to Holders of Securities of this series 
not less than 10 days prior to such Special Record Date, or be paid at any time 
in any other lawful manner not inconsistent with the requirements of any 
securities exchange on which the Securities of this series may be listed, and 
upon such notice as may be required by such exchange, all as more fully provided
in said Indenture.

        Payment of the principal of (and premium, if any) and any such interest
on this Security will be made at the Corporate Trust Office of the Trustee 
hereinafter referred to or such other office or agency of the Company as may be 
designated by the Company for that purpose in the Borough of Manhattan, the City
of New York, in such coin or currency of the United States of America as at the 
time of payment is legal lender for payment of public and private debts; 
provided, however, that at the option of the Company payment of interest may be 
made by check mailed to the address of the Person entitled thereto as such 
address shall appear in the Security Register.


        Reference is hereby made to the further provisions of this Security 
set forth on the reverse hereof, which further provisions shall for all purpose 
have the same effect as if set forth at this place.

        Unless the certificate of authentication hereon has been executed by the
Trustee referred to on the reverse hereof by manual signature, this Security 
shall not be entitled to any benefit under the Indenture or be valid or 
obligatory for any purpose.


<PAGE>
 
        IN WITNESS WHEREOF, the Company has caused this instrument to be duly
executed under its corporate seal.

Dated:  October 11, 1996



                                        BECTON, DICKINSON AND COMPANY

                                        By /s/ Edward J. Ludwig
                                           ------------------------------
                                         
Attest:



/s/ Bridget M. Healy
    -------------------------



                    TRUSTEE'S CERTIFICATE OF AUTHENTICATION

        This is one of the Securities of the series designated therein referred
to in the within-mentioned Indenture.


                                        THE CHASE MANHATTAN BANK,
                                          as Trustee



                                        By /s/ Frank Grippo
                                          -------------------------------
                                               Authorized Officer  



                          



                                      -3-
 

<PAGE>
 
 
                              REVERSE OF SECURITY


This Security is one of a duly authorized issue of securities of the Company
(herein called the "Securities"), issued and to be issued in one or more series
under an Indenture, dated as of December 1, 1982, as supplemented by the First
Supplemental Indenture thereto, dated as of May 15, 1986, and the Second
Supplemental Indenture thereto, dated as of January 10, 1995 (herein
collectively called the "Indenture"), between the Company and The Chase
Manhattan Bank (formerly known as Chemical Bank), successor by merger to
Manufacturers Hanover Trust Company, as Trustee (herein called the "Trustee",
which term includes any successor trustee under the Indenture), to which
Indenture and all further indentures supplemental thereto reference is hereby
made for a statement of the respective rights, limitations of rights, duties and
immunities thereunder of the Company, the Trustee and the Holders of the 
Securities and of the terms upon which the Securities are, and are to be, 
authenticated and delivered.  This Security is one of the series designated on 
the face hereof, limited in aggregate principal amount to $100,000,000.

        The Securities of this series are not subject to redemption.  The 
Indenture contains provisions for defeassance at any time of (a) the entire 
indebtedness of this Security and (b) certain restrictive covenants, in each 
case upon compliance by the Company with certain conditions set forth therein, 
which provisions apply to this Security.

        If an Event of Default with respect to Securities of this series shall
occur and be continuing, the principal of the Securities of this series may be
declared due and payable in the manner and with the effect provided in the
Indenture.

        The Indenture permits, with certain exceptions as therein provided, the 
amendment thereof and the modification of the rights and obligations of the 
Company and the rights of the Holders of the Securities of each series to be 
affected under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of 66 2/3% in principal amount of the Securities at the 
time Outstanding of each series to be affected.  The Indenture also contains 
provisions permitting the Holders of specified percentages in principal amount 
of the Securities of each series at the time Outstanding, on behalf of the 
Holders of all Securities of such series, to waive compliance by the Company 
with certain provisions of the Indenture and certain past defaults under the 
Indenture and their consequences.  Any such consent or waiver by the Holder of 
this Security shall be conclusive and binding upon such Holder and upon all 
future

                                      -4-
<PAGE>
 
Holders of this Security and of any Security issued upon the registration of 
transfer hereof or in exchange herefor or in lieu hereof, whether or not 
notation of such consent or waiver is made upon this Security.

        No reference herein to the Indenture and no provision of this Security 
or of the Indenture shall alter or impair the obligation of the Company, which 
is absolute and unconditional, to pay the principal of (and premium, if any) and
interest on this Security at the times, place and rate, and in the coin or 
currency, herein prescribed.

        As provided in the Indenture and subject to certain limitations therein 
set forth, the transfer of this Security is registrable in the Security 
Register, upon surrender of this Security for registration of transfer at the 
office or agency of the Company in any place where the principal of (and 
premium, if any) and interest on this Security are payable, duly endorsed by, 
or accompanied by a written instrument of transfer in form satisfactory to the 
Company and the Security Registrar duly executed by, the Holder hereof or his 
attorney duly authorized in writing, and thereupon one or more new Securities of
this series, of authorized denominations and for the same aggregate principal 
amount, will be issued to the designated transferee or transferees.

        The Securities of this series are issuable only in registered form 
without coupons in denominations of $1,000 and integral multiples thereof.  As 
provided in the Indenture and subject to certain limitations therein set forth, 
Securities of this series are exchangeable for a like aggregate principal amount
of Securities of this series of a different authorized denomination, as
requested by the Holder surrendering the same.

        No service charge shall be made for any such registration of transfer or
exchange, but the Company may require payment of a sum sufficient to cover any 
tax or other governmental charge payable in connection therewith.

        Prior to due presentment of this Security for registration of transfer, 
the Company, the Trustee and any agent of the Company or the Trustee may treat 
the Person in whose name this Security is registered as the owner hereof for all
purposes, whether or not this Security be overdue, and neither the Company, the 
Trustee nor any such agent shall be affected by notice to the contrary.

        All terms used in this Security which are defined in the Indenture shall
have the meanings assigned to them in the Indenture.



                                      -5-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission